|
|Section2= |Section3= }} PNU-142633 is an experimental drug candidate for the treatment of migraine. It exerts its effect as a selective, high affinity 5-HT1D receptor antagonist.〔(PNU 142633 ), Santa Cruz Biotechnology〕 PNU-142633 is well tolerated after oral administration. ==References== 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「PNU-142633」の詳細全文を読む スポンサード リンク
|